Subretinal fluid protective in macular atrophy in neovascular age-related macular degeneration Niveditha Subramani30 Dec 2022 9:45 AM ISTA recent study in Acta Opthamologica by Jorge Sanchez-Monroy and team reports that subretinal fluid appears to protect against Macular Atrophy (MA)....
Two regimens of intravitreal Conbercept improve outcomes in polypoidal choroidal vasculopathy: STAR study. Dr.Niharika Harsha B25 Nov 2022 8:00 PM ISTA new study found that both the fixed dosing regimen and the treat-and-extend regimen of intravitreal conbercept (IVC) resulted in improvement in...
Ranibizumab switch from aflibercept in nAMD patients linked to deterioration in visual acuity: Study Dr. Kamal Kant Kohli22 Sept 2022 8:00 PM ISTUSA: Switching from aflibercept to ranibizumab resulted in a reduction in visual acuity and worse anatomic results in patients with neovascular...
Ranibizumab Port Delivery System effective alternative for Neovascular Age-Related Macular Degeneration: JAMA Dr Ishan Kataria19 July 2022 7:45 PM ISTSince the introduction of anti-vascular endothelial growth factor (VEGF) agents, treatment outcomes for patients with neovascular age-related...
Biogen, Samsung Bioepis launch USFDA approved BYOOVIZ in US Ruchika Sharma5 Jun 2022 9:00 AM ISTBYOOVIZ is the first biosimilar launch in the U.S. under the Biogen and Samsung Bioepis' partnership.
Roche gets USFDA approval for wet AMD therapy Susvimo Ruchika Sharma23 Oct 2021 1:13 PM ISTBasel: Roche has recently announced that the U.S. Food and Drug Administration (FDA) has approved Susvimo (ranibizumab injection) 100 mg/mL for...
Brolucizumab efficacious and safe in Neovascular Age-Related Macular Degeneration: BRAILLE Study Dr Ishan Kataria14 Oct 2021 9:00 AM ISTAge-related macular degeneration (AMD) is a chronic, progressive disease of the central retina and a major cause of irreversible vision loss...
Abicipar holds potential as long acting treatment in neovascular AMD: Study Medha Baranwal7 Dec 2020 9:15 AM ISTUSA: Abicipar was shown to have a longer duration of effect in patients with treatment-naive neovascular age-related macular degeneration (nAMD),...
